Tollon C, Soulié M, Aziza R, Escourrou G, Pontonnier F, Plante P
Service de Chirurgie urologie et Andrologie, CHU Rangueil, Toulouse, France.
Prog Urol. 1998 Apr;8(2):223-31.
Prostate cancer is clinically understaged in 50% of cases. It was improved with the use of random biopsies, PSA analysis (balanced and unbalanced) and Gleason grade on biopsies. Traditional imaging techniques such as endorectal ultrasonography and CT Scan are known to be of no interest. MRI is a non-evasive technique which allows the three dimensional study of an organ with a high quality of tissue contrast. Moreover, the positioning of surface antennae or "phased array" allowed improvement in spatial resolution.
To determine whether MRI allows an accurate staging of clinically localised adenocarcinoma by the direct estimation of capsular effraction, measure of glandular and tumor volumes and finally by obtaining reliable PSAd.
A prospective study was done from March 1995 to November 1996 on 55 patients with a clinically localised adenocarcinoma. MRI 1 Tesla Imager (SIEMENS), pelvic phased array antennae. FSE sequences (T1 and T2), axial and frontal. Evaluation of volumes by on-screen. Standford protocol for histo-pathologic reading on the axial cuts. Direct planimetry on a millimetre paper.
Reliable estimation of glandular volume (average difference 0.7 cc). Sub-evaluation of tumoral volume (average difference 1.04 cc) with a 30% margin of error, accuracy 87%. Tumoral stage exact in almost 90% of the cases with a PPV of 94%.
Prostatic MRI, using surface antennae, allows to complete the conventional stage by stage development by correctly diagnosing 75% of locally evolved stages. Its limits are linked to the nature of the signal of the tumorous tissue as to the localisation of neoplasic lesions.
50%的前列腺癌病例在临床上分期过低。随机活检、PSA分析(平衡和不平衡)以及活检时的 Gleason分级的应用改善了这一情况。诸如直肠内超声和CT扫描等传统成像技术已被证明并无帮助。MRI是一种非侵入性技术,能够对器官进行三维研究,具有高质量的组织对比度。此外,表面天线或“相控阵”的定位提高了空间分辨率。
通过直接评估包膜侵犯、测量腺体和肿瘤体积以及最终获得可靠的前列腺特异性抗原密度(PSAd),确定MRI是否能对临床局限性腺癌进行准确分期。
1995年3月至1996年11月对55例临床局限性腺癌患者进行了一项前瞻性研究。使用1特斯拉MRI成像仪(西门子),盆腔相控阵天线。FSE序列(T1和T2),轴向和冠状面。通过屏幕评估体积。采用斯坦福协议对轴向切片进行组织病理学解读。在毫米纸上直接进行面积测量。
腺体体积估计可靠(平均差异0.7立方厘米)。肿瘤体积评估偏低(平均差异1.04立方厘米),误差 margin为30%,准确率87%。在几乎90%的病例中肿瘤分期准确,阳性预测值为94%。
使用表面天线的前列腺MRI能够通过正确诊断75%的局部进展期来完善传统的分期方法。其局限性与肿瘤组织信号的性质以及肿瘤性病变的定位有关。